These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1066 related items for PubMed ID: 16532321
1. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis. Verit FF, Geyikli I, Yazgan P, Celik A. Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321 [Abstract] [Full Text] [Related]
2. Serum prolidase activity in postmenopausal osteoporosis. Namiduru ES, Binnur Erbagci A, Celik A, Yilmaz M, Tarakçioglu M. Minerva Med; 2007 Dec; 98(6):647-51. PubMed ID: 18299678 [Abstract] [Full Text] [Related]
3. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944 [Abstract] [Full Text] [Related]
4. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K. Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488 [Abstract] [Full Text] [Related]
5. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. Shaarawy M, Zaki S, Sheiba M, El-Minawi AM. Clin Lab; 2003 Mar 15; 49(11-12):625-36. PubMed ID: 14651333 [Abstract] [Full Text] [Related]
6. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women. Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E. J Obstet Gynaecol Res; 2009 Feb 15; 35(1):152-9. PubMed ID: 19215563 [Abstract] [Full Text] [Related]
7. Biochemical markers as predictors of rates of bone loss after menopause. Rogers A, Hannon RA, Eastell R. J Bone Miner Res; 2000 Jul 15; 15(7):1398-404. PubMed ID: 10893690 [Abstract] [Full Text] [Related]
8. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women. Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T. Menopause; 2008 Jul 15; 15(2):369-73. PubMed ID: 17882010 [Abstract] [Full Text] [Related]
9. Relationship of bone turnover to bone density and fractures. Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL. J Bone Miner Res; 1997 Jul 15; 12(7):1083-91. PubMed ID: 9200008 [Abstract] [Full Text] [Related]
10. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women. Uretmen S, Gol M, Cimrin D, Irmak E. Eur J Obstet Gynecol Reprod Biol; 2005 Nov 01; 123(1):67-71. PubMed ID: 16051419 [Abstract] [Full Text] [Related]
11. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women. Makker A, Singh MM, Mishra G, Singh BP, Jain GK, Jadhav S. Menopause; 2012 Jun 01; 19(6):642-9. PubMed ID: 22240638 [Abstract] [Full Text] [Related]
12. Femoral neck osteopenia in patients with inflammatory bowel disease. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Am J Gastroenterol; 1998 Sep 01; 93(9):1483-90. PubMed ID: 9732930 [Abstract] [Full Text] [Related]
13. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB. J Bone Miner Res; 2005 Jun 01; 20(6):962-70. PubMed ID: 15883636 [Abstract] [Full Text] [Related]
14. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Akin O, Göl K, Aktürk M, Erkaya S. Gynecol Endocrinol; 2003 Feb 01; 17(1):19-29. PubMed ID: 12724015 [Abstract] [Full Text] [Related]
15. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women]. Guo LJ, Luo XH, Wu XP, Xie H, Zhou HD, Zhang H, Cao XZ, Liao EY. Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):734-7. PubMed ID: 15949377 [Abstract] [Full Text] [Related]
16. Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Shaarawy M, Abassi AF, Hassan H, Salem ME. Fertil Steril; 2003 Apr 23; 79(4):919-24. PubMed ID: 12749431 [Abstract] [Full Text] [Related]
17. Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis. Frost ML, Fogelman I, Blake GM, Marsden PK, Cook G. J Bone Miner Res; 2004 Nov 23; 19(11):1797-804. PubMed ID: 15476579 [Abstract] [Full Text] [Related]
18. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy? Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P. J Bone Miner Res; 1997 Jan 23; 12(1):78-88. PubMed ID: 9240729 [Abstract] [Full Text] [Related]
19. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH. Bone; 2010 Apr 23; 46(4):935-9. PubMed ID: 20060081 [Abstract] [Full Text] [Related]
20. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis. Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE. Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460 [Abstract] [Full Text] [Related] Page: [Next] [New Search]